Sage, PhaseV, Greater Good Health
Midas Healthcare Solutions Raises $2M in Funding
Healthcare Solutions, Inc., a Cleveland, OH-based developer of technology-driven solutions to promote the safe use, storage, return, and disposal of controlled substances and other dangerous medications in hospitals and other healthcare institutions, raised $2m in funding.
MCPC Healthcare Investment, LLC, the newly formed investment arm of Cleveland-based MCPC*, made the investment.
The company intends to use the funds for expansion of its product development efforts in preparation for the 2024 product rollout.
This investment comes as the healthcare industry continues to be plagued by the diversion of opioids and other dangerous medications, enabling caregivers with substance use disorders to endanger themselves, their colleagues, and their patients. Recent data suggest that 1 in 100 healthcare workers diverts drugs in the clinical setting, although industry leaders acknowledge that the actual figure is likely substantially higher.
Led by Michael LaFauci, RPh, CEO and founder, Midas firstly will market the Verified Institutional Environment for Wasting (V.I.E.W.), a small dedicated workstation for the safe and responsible handling of excess medication not needed for patient administration. The V.I.E.W. enables a verified method of “wasting” excess inventory using several features: high-acuity camera and scanning technology, a video queue process that eliminates the immediate need to source an in-person witness to observe the process, and the ability to sequester samples for additional analysis.
The company will soon begin piloting the V.I.E.W. system at a number of tertiary care adult hospitals and a leading children’s hospital to demonstrate the value of increased medication security, validation and verification of witnessed wasting events, and increased operational efficiencies.
https://www.finsmes.com/2023/10/midas-healthcare-solutions-raises-2m-in-funding.html?mc_cid=b4a72f0210&mc_eid=df5e82ed1d
LighthouseAI Closes $4.6M Seed Funding
LighthouseAI, a Los Angeles, CA-based company which specializes in compliance solutions for the pharmaceutical supply chain, raised $4.6M in Seed funding.
The round was led by Healthy Ventures and BluePointe Ventures, with participation from Eileses Capital, Bertelsmann Next, The Legal Tech Fund, and additional angel investors.
The company intends to use the funds to accelerate the development and growth of their flagship product suite of compliance automation solutions for the pharmaceutical supply chain.
Led by CEO Sumeet Singh, LighthouseAI specializes in AI-driven solutions to navigate the complex landscape of regulatory compliance in the life sciences supply chain. LighthouseAI’s product suite, rooted in the RegTech space, is specifically designed to reduce risk and cost associated with compliance. LighthouseAI Intelligence™ utilizes artificial intelligence to identify facility-specific requirements and automate regulatory surveillance across all state and federal jurisdictions, tailored to a user’s exact business model and product portfolio. As the Intelligence product solution identifies these requirements, LighthouseAI Management™ provides a system for efficient tracking and handling of responses, including secure uploading and storage of crucial documents, task management, and activity-level tracking, enabling the user to manage all related activities and obligations.

LighthouseAI Closes $4.6M Seed Funding
LighthouseAI, a Los Angeles, CA-based company which specializes in compliance solutions for the pharmaceutical supply chain, raised $4.6M in Seed funding
Rymedi Raises $9M in Series A Funding
Greenville, SC-based healthcare data exchange platform with advanced blockchain security, raised $9m in Series A funding.
The round was co-led by RW3 Ventures and White Star Capital with participation from Blockchange Ventures, Avalanche’s Blizzard Fund, and strategic angel investors from the healthcare industry.
The company intends to use the funds to expand the reach of the platform.
Founded in 2018 by David Stefanich, CEO, Rymedi provides a blockchain powered healthcare data exchange platform that meets multijurisdictional compliance so that data is securely transferred while meeting healthcare compliance standards worldwide. The platform currently supports Clemson University and many other large organizations throughout the world. With over 1 million lives on the platform in over 1,200 locations in the US, Africa, and Australia, it is utilized for occupational health, laboratories, diagnostic devices, and clinical trials.

Rymedi Raises $9M in Series A Funding
Rymedi, a Greenville, SC-based healthcare data exchange platform with advanced blockchain security, raised $9m in Series A funding
Sage secures $15M to improve quality of care for older adults and combat caregiver burnout
Sage, a technology company reinventing care for older adults through its unified care coordination platform, has raised $15 million in Series A funding led by new investor Maveron. The round also includes all major investors including Goldcrest Capital, ANIMO Ventures, and Distributed Ventures. Natalie Dillon, partner at Maveron, will be joining the Sage board of directors as the first outside board member.
In the wake of widespread healthcare worker shortages and increasing numbers of older adults as a percent of the U.S. population, Sage technology fills a critical gap within senior living communities. Sage offers a modern care coordination platform providing incident response capabilities and giving care teams access to robust data-driven insights through an integrated communications app they can access easily through a smartphone. Communities enabled with Sage have seen caregivers' response times improve by as much as 50 percent while also improving caregiver satisfaction and up to a 40 percent reduction in caregiver churn. Sage has partnered with hundreds of senior living communities across the U.S. and has seen resident and family complaints reduced by up to 90%.

Sage secures $15M to improve quality of care for older adults and combat caregiver burnout
/PRNewswire/ -- Sage, a technology company reinventing care for older adults through its unified care coordination platform, has raised $15 million in Series A...
PhaseV raises $15m for ML technology to optimise clinical trial design
Israel-based PhaseV, a company that develops machine learning (ML) technology to optimise trial design and retrospective analysis, has raised $15m in funding. PhaseV has raised the funding led by Viola Ventures and Exor Ventures, including participation from LionBird and a group of prominent angel investors.
The secured funds will be used to further advance PhaseV’s proprietary ML technology to accelerate drug development by creating more efficient, targeted, and ultimately more successful clinical trials. The company claims its ML technology provides clinical development teams with an advanced ability to retrospectively analyse and optimally design studies, as well as adapt in real-time throughout the trial. It can also significantly accelerate the clinical drug development process and increase certainty along the way.

PhaseV raise $15m for ML technology to optimise trial design
PhaseV will use the funds to further develop its ML technology which optimises trial design and provides retrospective data analysis.
Greater Good Health Raises $20M to Address Primary Care Crisis and Advance Value-Based Care for Seniors
Greater Good Health, a healthcare organization enabling and expanding access to value-based care for seniors through a Nurse Practitioner-led model, today announced it has closed a $20M Series A financing led by Flare Capital Partners. Greater Good Health received participation from existing investors including LRVHealth, Health Velocity Capital, Martin Ventures, and Optum Ventures, as well as participation from new strategic investors.
Greater Good Health will use the newly raised funding to grow and scale the organization's private-labeled, integrated clinical solutions while also fueling the development of its own primary care clinics, starting first with a value-based partnership with a national Medicare Advantage health plan to open clinics serving seniors in Montana later this year. With the opening of these clinics, Greater Good Health will be delivering a differentiated, senior-centric experience that includes an outcomes-focused care model, prompt access to care, focus on relationship-building and treating the whole person, investment in community and social connection, and support navigating Medicare plans and benefits.
Greater Good Health is a healthcare organization enabling and expanding access to value-based, holistic primary care. Through an innovative Nurse Practitioner-led model, Greater Good Health partners with health plans to build primary care practices in underserved, often rural, communities, and partners with risk-bearing organizations to deploy private-labeled clinical programs that enable the shift to value-based, outcomes-focused care. Greater Good Health's proven care model and clinical programs benefit patients, providers, and payers alike, improving outcomes, reducing costs, and delivering a best-in-class patient experience.

Greater Good Health Raises $20M to Address Primary Care Crisis and Advance Value-Based Care for Seniors | Business Wire
Greater Good Health, expanding access to value-based care, today announced it has closed a $20M Series A financing led by Flare Capital Partners.
CVS, Mayo Clinic, Spark Capital back Abridge's $30M round to scale up generative AI-powered notetaking for doctors
Abridge, a startup that developed artificial intelligence-based documentation solutions for healthcare, has seen rapid growth in the past year, propelled by a "tornado of tailwinds," according to company CEO Shivdev Rao, M.D.
The company's technology sits at the intersection of two massive trends in healthcare—clinician burnout and accelerated adoption of generative AI.
"This problem around clinician burnout has risen to the level of a public health emergency," Rao said in an interview. "Now, health systems have this top priority to figure out a solution for it and the old ways of solving it aren't really available to them; you can't raise prices. And certainly, it's difficult to solve the supply-demand mismatch that we're having in healthcare delivery by asking clinicians to do more when two out of five doctors are saying that they want to leave healthcare in the next couple of years. So they need technology."
"The other tailwind that we've been right at the intersection of is generative AI. What ChatGPT has done for all of us in terms of making it top of mind is demonstrating that this technology can be part of the solution," he said. 'Over the last 10 to 12 months, we've been able to demonstrate at scale at large health systems that this technology can improve the care delivery experience and it can unburden clinicians from the clerical work that's crushing their souls at night," said Rao, who, along with being a co-founder of Abridge, also is a practicing cardiologist who previously served as an executive at UPMC's venture arm.
Abridge launched in 2018 and uses AI to increase the speed and accuracy of medical note-taking, leveraging a proprietary dataset derived from more than 1.5 million medical encounters. Around 5,000 doctors currently use the company's software, which automatically converts a patient-clinician conversation into a structured clinical note draft in real-time.
https://www.fiercehealthcare.com/ai-and-machine-learning/cvs-mayo-clinic-spark-capital-back-abridges-30m-round-scale-generative-ai?mc_cid=b4a72f0210&mc_eid=df5e82ed1d